Ambruso Daniel MD entered the industry of Blood Related Health Services in 0 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6211110, which describes it as a Blood Related Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Blood Related Health Services. The business provides service to the B2C market.
To acquire more information, please contact Daniel Ambruso by calling (303) 341-4000 during business hours. You can also write to the business’ Single Location at 717 Yosemite St, Denver, Colorado CO 80230. You can also visit the company’s website at bonfils.org. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Ambruso Daniel MD |
| Representative: | Daniel Ambruso |
| Place of Business: | 717 Yosemite St, Denver, CO 80230 |
| Contact Number: | (303) 341-4000 |
| Website: | bonfils.org |
| Type of Service: | Blood Related Health Services |
| SIC Number: | 8099 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2C (Business to Consumer) |
| Income/Year: | $500.000 to $999.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Ambruso Daniel MD is a company operating from Denver, Colorado providing professional Blood Related Health Services and relevant B2C variables. It was founded in 0 and registered with the SIC code 8099 as Blood Related Health Services, and with the NAICS code 6211110 as Blood Related Health Services.
With a current employee count of 1 to 4, Ambruso Daniel MD has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Daniel Ambruso at (303) 341-4000 for related queries, or to locate its Single Location using the coordinates 39.72745,-104.88746.
The Single Location can also be found at the street address 717 Yosemite St in Denver, Colorado 80230 and can be engaged online through the company website at bonfils.org, the company Twitter , and Facebook page .